| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2007 | CN101032464A Combination containing rimonabant and polyvinyl pyrrolidone, solid dispersion and the preparing and medicine application thereof |
| 09/12/2007 | CN101032463A Sirolimus injection and preparing technique thereof |
| 09/12/2007 | CN101032462A Mexiletine Hydrochloride slow release reagent and preparing method thereof |
| 09/12/2007 | CN101032336A Pearl flavone nutrient health care food and preparation process thereof |
| 09/12/2007 | CN101032278A Combination including calcium conjugated linoleic acid and producing method thereof |
| 09/12/2007 | CN100336833C Companumoea root polyose, derivative and its preparing method and use |
| 09/12/2007 | CN100336813C Oxazoles as mGluR1 enhancer |
| 09/12/2007 | CN100336809C Peptide deformylase inhibitors |
| 09/12/2007 | CN100336797C Tetra substituted chalcone derivative and preparing method and use |
| 09/12/2007 | CN100336550C Bamboo liquid health plaster |
| 09/12/2007 | CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 09/12/2007 | CN100336516C Ginkgo leaf extract and dipyridamole compound medicine and its preparing method |
| 09/12/2007 | CN100336514C Medicine for treating beri-beri and its preparing method and use |
| 09/12/2007 | CN100336513C Pharmaceutical preparation ingested via nose for treating ischemia cerebrovascular disease |
| 09/12/2007 | CN100336512C Bambbo leaf flavone freeze dried powser injection, its preparation method and application |
| 09/12/2007 | CN100336511C Release-controlled oral Roxithromycin formulation |
| 09/12/2007 | CN100336510C 头孢匹胺组合物 Cefpiramide composition |
| 09/12/2007 | CN100336509C Aripiprazole orally disintegrating tablet formulation and its preparing method |
| 09/12/2007 | CN100336508C Stable palonosetron injection |
| 09/12/2007 | CN100336507C Nimoldipine new nano liposome, its precursor freeze dryed matter and its preparing method |
| 09/12/2007 | CN100336506C Orally disintegrating tablet of phentolamine mesylate and its preparation method |
| 09/12/2007 | CN100336505C Soybean aglycone soft capsule and its preparing method |
| 09/12/2007 | CN100336504C Beta-Asarone transdermal plaster |
| 09/12/2007 | CN100336501C Cuyantong slow-releasing round-particle composition and preparation method |
| 09/11/2007 | USRE39836 Macrolide antinfective agents |
| 09/11/2007 | US7268245 For therapy of cellular proliferative diseases |
| 09/11/2007 | US7268244 Monoimine ligand platinum analogs |
| 09/11/2007 | US7268240 Flavanoid dimers or trimers, formed by oligomerization, then etherifying, esterifying or glycosylating to obtain drugs used as anticarcinogenic agents |
| 09/11/2007 | US7268232 Androgen receptor modulators and method of treating disease using the same |
| 09/11/2007 | US7268230 Quinazoline compounds |
| 09/11/2007 | US7268227 Posh nucleic acids, polypeptides and related methods |
| 09/11/2007 | US7268222 For use in therapeutic, diagnostic, and pharmacogenomic applications |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268166 Substituted 4-phenyl amino butane; spinal chord injuries, neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics |
| 09/11/2007 | US7268164 Administering an amino carbonyl compound |
| 09/11/2007 | US7268163 Method for treating an inflammation or lesion caused by a virus |
| 09/11/2007 | US7268162 Aloe-emodin derivatives and their use in the treatment of neoplasias |
| 09/11/2007 | US7268161 Using mixtur eof serotonin reuptake inhibitor, such as phenlemine, 5-hydroxytrophophan, Vitamin C, Vitamin B6, tyrosine, calcium |
| 09/11/2007 | US7268160 A therapeutic or prophylactic agent for a disease that requires enhancement of nerve growth factor production, e.g., butein; nervous system disorders; Alzeimher's disease; additive for foods, beverages and feeds |
| 09/11/2007 | US7268159 Indolecarboxylic acid derivatives as plasminogen activator inhibitor inhibitors; anticoagulant, antiischemic, and anticarcinogenic agents; noninsulin-dependent diabetes, polycystic ovarian syndrome, cardiovascular disorders, atherosclerosis, alzheimer*s disease, chronic obstructive pulmonary disease |
| 09/11/2007 | US7268158 6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH) |
| 09/11/2007 | US7268157 Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 09/11/2007 | US7268156 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment |
| 09/11/2007 | US7268155 Photosensitizer conjugates for pathogen targeting |
| 09/11/2007 | US7268154 Substituted triazole compounds |
| 09/11/2007 | US7268153 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268151 2-[4-(3-Methoxy-4-pyridin-2-ylphenyl)-2H-1,2,3-triazol-2-yl]pyridine; psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders |
| 09/11/2007 | US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 09/11/2007 | US7268149 Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders |
| 09/11/2007 | US7268148 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 09/11/2007 | US7268147 For therapy of inflammatory, allergic and respiratory diseases |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268145 Thiobenzimidazole derivatives |
| 09/11/2007 | US7268144 Regiospecific synthesis of rapamycin 42-ester derivatives |
| 09/11/2007 | US7268143 Isoquinoline derivatives and methods of use thereof |
| 09/11/2007 | US7268142 4-chloro-N-[2-(6,7-dimethoxy-quinazolin-4-yl)-1,2,3,4-tetrahydro-isoquinolin-7-yl]-benzenesulfonamide; schizophrenia, central nervous system disorders |
| 09/11/2007 | US7268141 Xanthine phosphodiesterase V inhibitors |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268139 Methods of promoting osteogenesis |
| 09/11/2007 | US7268138 Compounds, methods and pharmaceutical compositions for inhibiting PARP |
| 09/11/2007 | US7268137 Retinal detaching membranes for eyes and vision |
| 09/11/2007 | US7268136 Compositions useful as inhibitors of protein kinases |
| 09/11/2007 | US7268135 Biaryl sulfonamides and methods for using same |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/11/2007 | US7268133 Cannabinoid receptor ligands and uses thereof |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268131 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma |
| 09/11/2007 | US7268130 Benzothiadiazine compounds |
| 09/11/2007 | US7268129 Fluorinated benzothiadiazine compounds |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268127 Azaindoles having serotonin receptor affinity |
| 09/11/2007 | US7268126 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7268124 For therapy of cancer, for modulating testicular function, insulin resistance, obesity |
| 09/11/2007 | US7268123 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them |
| 09/11/2007 | US7268122 Viricides; aids therapy |
| 09/11/2007 | US7268121 Suppression of nuclear factor-κB dependent processes using oligonucleotides |
| 09/11/2007 | US7268119 Tricyclic nucleosides or nucleotides as therapeutic agents |
| 09/11/2007 | US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 09/11/2007 | US7268109 Method for reducing pain |
| 09/11/2007 | US7268106 Pearlescent appearance and in stability of a pearling agent (particularly, long-term storage stability at high temperatures |
| 09/11/2007 | US7267990 Chelation of charged and uncharged molecules with porphyrin-based compounds |
| 09/11/2007 | US7267977 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 09/11/2007 | US7267949 Composition comprising methylphenidate and another drug |
| 09/11/2007 | US7267830 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
| 09/11/2007 | US7267828 Enhancing the photostable silver in medical equipment |
| 09/11/2007 | US7267827 For therapy of inflammatory and pain of a traumatic or pathologic origin |
| 09/11/2007 | US7267822 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 09/11/2007 | US7267821 Antitumor agents; leukemia; |
| 09/11/2007 | US7267815 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | CA2447210C Delivery of aerosols containing small particles through an inhalation route |
| 09/11/2007 | CA2432904C Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| 09/11/2007 | CA2432900C Induced phase transition method for the production of microparticles containing hydrophilic active agents |
| 09/11/2007 | CA2432064C Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/11/2007 | CA2429114C Treatment of premature ejaculation |
| 09/11/2007 | CA2426275C Ectoparasitic insect pest controllers for animals and their usage |
| 09/11/2007 | CA2397262C Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
| 09/11/2007 | CA2388802C Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |